Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Junshi Biosciences (688180 CH)
Watchlist
43
Analysis
Health Care
•
China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Shanghai Junshi Biosciences
•
03 Sep 2023 09:06
China Healthcare Weekly (Sep.1) - China's New IPO Reform, Financing Environment, Junshi Biosciences
CSRC issued new policies related to IPO reform in China.As IPO rules in A-share face adjustments, fundraising ecology will change.Junshi is far...
Xinyao (Criss) Wang
Follow
426 Views
Share
bullish
•
Eoptolink Technology
•
04 Jul 2023 05:40
CSI500 Index Rebalance Preview: Potential Adds Outperforming Potential Deletes
We see 50 changes a side for the CSI500 in Dec. The Industrials sector could take a lot of index spots from Materials as one-way turnover exceeds...
Brian Freitas
Follow
496 Views
Share
bullish
•
Quantitative Analysis
•
12 Mar 2023 10:30
A-H Premium Weekly (Mar 10th): China Shenhua, PetroChina, China Southern, ZTE, CRRC, CICC
We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Shenhua, PetroChina, China Southern, ZTE, CRRC, CICC.
Ke Yan, CFA, FRM
Follow
368 Views
Share
bearish
•
Quantitative Analysis
•
19 Feb 2023 15:25
A-H Premium Weekly (Feb 17th): China Shenhua, PetroChina, GWM, First Tractor
We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Shenhua, PetroChina, GWM, First Tractor
Ke Yan, CFA, FRM
Follow
343 Views
Share
bullish
•
Quantitative Analysis
•
13 Feb 2023 08:00
A-H Premium Weekly (Feb 10th): Premium Compressed for Utilities
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Great Wall Motor, Huadian, Huaneng, Datang Intl.
Ke Yan, CFA, FRM
Follow
256 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x